Institutional Ownership
Leap Therapeutics Inc
CUSIP 52187K200COM NEWCYPHQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
19.9%
Max % of class reported
Institutional Holders
38
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Gilead Sciences, Inc. | 13G/A | — | — | SEC |
| 2 | Nov 21, 2025 | Winklevoss Capital Fund, LLC | 13D/A | 19.9% | — | SEC |
| 3 | Nov 18, 2025 | Severns Sean Michael | 13G | 10.6% | 6.00M | SEC |
| 4 | Oct 16, 2025 | Winklevoss Capital Fund, LLC | 13D | 19.9% | — | SEC |
| 5 | Aug 14, 2025 | Samsara Biocapital, L.P. | 13G/A | — | 913.30M | SEC |
| 6 | Feb 14, 2025 | Balyasny Asset Management L.P. | 13G/A | — | — | SEC |
| 7 | Nov 14, 2024 | Balyasny Asset Management L.P. | 13G | 8.1% | 3.09M | SEC |
| 8 | Oct 31, 2024 | Beigene, Ltd. | 13D/A | 3.2% | 1.22M | SEC |
| 9 | Oct 31, 2024 | Beigene, Ltd. | 13D/A | — | — | SEC |
| 10 | Feb 14, 2024 | Perceptive Advisors LLC | 13G/A | 4.0% | 1.07M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 2.34M | $1.86M |
| 2 | Renaissance Technologies LLC | 725.1K | $576.2K |
| 3 | Geode Capital Management, LLC | 571.1K | $453.9K |
| 4 | Susquehanna International Group, LLP | 263.0K | $208.9K |
| 5 | Ubs Group AG | 171.1K | $136.0K |
| 6 | Lpl Financial LLC | 162.5K | $129.1K |
| 7 | State Street Corp | 140.1K | $111.3K |
| 8 | Group One Trading LLC | 107.4K | $85.4K |
| 9 | Texas Capital Bank Wealth Management Services Inc | 104.2K | $82.8K |
| 10 | Northern Trust Corp | 87.6K | $69.6K |